A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction

Erstveröffentlichung
2010Authors
Moehler, Markus
Kanzler, Stephan
Geissler, Miriam
Raedle, Jochen
Ebert, Matthias Philip
Wissenschaftlicher Artikel
Published in
Annals of Oncology ; 21 (2010), 1. - S. 71-77. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1093/annonc/mdp269Institutions
UKU. Klinik für Innere Medizin ISubject headings
[Free subject headings]: capecitabine | cisplatin | elderly patients | gastric cancer | irinotecan | ADVANCED GASTRIC-CANCER | COLORECTAL-CANCER | 1ST-LINE TREATMENT | ORAL CAPECITABINE | FOLINIC ACID | COMBINATION CHEMOTHERAPY | PLUS CISPLATIN | TRIAL | FLUOROURACIL | LEUCOVORIN[DDC subject group]: DDC 610 / Medicine & health